Guotai Xu

机构：National Institute of Biological Sciences, Beijing, Tsinghua University · ORCID：0000-0001-5265-3407

发表论文 54 篇 · 总被引 3157 次 · h-index 15

代表论文

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers (2021 · Nature Communications · 被引 30)
Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance (2022 · Frontiers in Immunology · 被引 27)
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers (2025 · Science Translational Medicine · 被引 7)
EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers (2025 · Cellular Oncology · 被引 2)
Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers (2026 · Molecular Carcinogenesis)
Abstract P2-03-17: Targeting NR2F2 overcomes multiple forms of endocrine resistance (2025 · Clinical Cancer Research)